Dr Tiffany Vora: Is 150 Really the Next 80? | EDGE 2026
Thriving and Well-Being
•
06-May-2026
In this EDGE - Beyond The Stage 1:1, Dr Tiffany Vora unpacks what “Is 150 the next 80?” really means - not just living longer, but extending healthspan. She shares the biotech breakthroughs making this plausible, from CRISPR gene editing to AI-enabled biology, and explains how leaders should rethink performance culture, succession planning, and multigenerational teams in a world of longer careers. She also flags the ethical risk of widening inequality if longevity tools remain accessible only to those with money.
Takeaways:
• “Healthspan” matters more than lifespan - the goal is longer, healthier productive lives.
• Biotech breakthroughs like “CRISPR” plus AI can accelerate medical advances in the next decade.
• Leaders should prepare now for longer careers and the inequality risks of unequal access to longevity tools.
Up Next in Thriving and Well-Being
-
The Other Revolution - GLP-1s and the...
GLP-1 medications are transitioning from groundbreaking treatments to widely used solutions, and the scope of this shift is becoming increasingly evident. These drugs can reduce calorie intake by 15–35%, result in fewer sick days, have millions of active users, and are prompting the development o...
-
S02E01 Q&A - Damien Keogh: A New Lang...
In this TLA S02 session, Damien Keogh explores why the real challenge in longevity may not be scientific discovery alone, but how the space is defined, measured, and evaluated. Drawing from drug discovery, venture capital, traditional Chinese medicine, evolutionary biology and AI, he offers a pra...
-
S02E01 - Damien Keogh: A New Language...
In this TLA S02 session, Damien Keogh explores why the real challenge in longevity may not be scientific discovery alone, but how the space is defined, measured, and evaluated. Drawing from drug discovery, venture capital, traditional Chinese medicine, evolutionary biology and AI, he offers a pra...
